🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To compare the efficacy of inebilizumab (MEDI-551) versus placebo in reduci...
Status
Completed
Location
Research Site
Start Date
2015-04-01
Trial ID
NCT02200770
Treatments Being Tested
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Research Site
Start Date
2011-05-25
Trial ID
NCT01957579
Treatments Being Tested
The overall purpose of the study is to determine if MEDI-551, when used in ...
Status
Completed
Location
Research Site
Start Date
2012-02-27
Trial ID
NCT01453205
Treatments Being Tested
Randomized, double-blind, placebo-controlled, Phase 3, parallel-group study...
Status
Active Not Recruiting
Location
Viela Bio Investigative Site - 1015
Start Date
2020-10-15
Trial ID
NCT04524273
Treatments Being Tested
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of ME...
Status
Completed
Location
Research Site
Start Date
2014-12-01
Trial ID
NCT02271945
Treatments Being Tested
The overall purpose of the study was to determine if MEDI-551, when used in...
Status
Completed
Location
Research Site
Start Date
2012-02-07
Trial ID
NCT01466153
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose of thi...
Status
Completed
Location
Research Site
Start Date
2010-04-16
Trial ID
NCT00983619
Determine the progression free survival of high-risk or relapsed Multiple M...
Status
Terminated
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2017-09-27
Trial ID
NCT03218163
Treatments Being Tested
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Research Site
Start Date
2010-03
Trial ID
NCT00946699
The purpose of this study is to evaluate the safety and tolerability of asc...
Status
Completed
Location
Research Site
Start Date
2012-04-24
Trial ID
NCT01585766